MBTPS1 and head and neck squamous cell carcinoma: The presence of intracellular elevated SphK1 expression correlates with clinical failure and poor survival in HNSCC patients and S1P-targeted therapy was put forward as a possible inclusion for resistant, hard-to-treat, HNSCC tumours [97].